Cinacalcet normalizes serum calcium in a double-blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery - Concepedia

Concepedia

Publication | Open Access

Cinacalcet normalizes serum calcium in a double-blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery

DOI Full Paper Access

79

Citations

29

References

2015

Year

Aliya Khan, John P. Bilezikian, Henry G. Bone, Andrey Gurevich, P. Lakatos, Waldemar Misiorowski, Liudmila Rozhinskaya, Marie‐Louise Trotman, Miklós Tóth

European Journal of Endocrinology

Abstract

These results demonstrate that cinacalcet normalizes serum calcium in this PHPT population and appears to be well tolerated.

References

	Year	Citations
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. John E. Ware, Cathy D. Sherbourne PubMed Quality Of LifeHealth OutcomeItem Response TheoryGeriatric MedicinePrimary Care	1992	34K
The MOS 36-ltem Short-Form Health Survey (SF-36) John E. Ware, Cathy D. Sherbourne Medical Care NursingQuality Of LifePrimary CareHealth PolicyHealthy Aging	1992	29.1K
Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Third International Workshop John P. Bilezikian, Aliya Khan, John T. Potts The Journal of Clinical Endocrinology & Metabolism	2009	1.5K
Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop John P. Bilezikian, Maria Luisa Brandi, Richard Eastell, The Journal of Clinical Endocrinology & Metabolism Asymptomatic PhptNeuroendocrinologyGynecologyParathyroid DiseaseFourth International Workshop	2014	1.2K
Presentation of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop Shonni J. Silverberg, E. Michael Lewiecki, Leif Mosekilde, The Journal of Clinical Endocrinology & Metabolism	2009	685
Cinacalcet Hydrochloride Maintains Long-Term Normocalcemia in Patients with Primary Hyperparathyroidism Munro Peacock, John P. Bilezikian, Preston Klassen, The Journal of Clinical Endocrinology & Metabolism	2005	463
Pharmacodynamics of the Type II Calcimimetic Compound Cinacalcet HCl Edward F. Nemeth, Haynes Heaton, Michael A. Miller, Journal of Pharmacology and Experimental Therapeutics	2004	365
Achieving NKF-K/DOQI™ bone metabolism and disease treatment goals with cinacalcet HCl Sharon M. Moe, Glenn M. Chertow, Jack W. Coburn, Kidney International Bone DiseaseBone HealthMedicineNkf-k/doqi™ Bone MetabolismDisease Treatment Goals	2005	326
Alendronate in Primary Hyperparathyroidism: A Double-Blind, Randomized, Placebo-Controlled Trial Aliya Khan, John P. Bilezikian, A W Kung, The Journal of Clinical Endocrinology & Metabolism	2004	279
Cinacalcet Hydrochloride Reduces the Serum Calcium Concentration in Inoperable Parathyroid Carcinoma Shonni J. Silverberg, Mishaela R. Rubin, Charles Faiman, The Journal of Clinical Endocrinology & Metabolism	2007	269

Page 1